AstraZeneca PLC
1568.00
13-مارس-25 12:04:24
15 متأخرة بدقائق
الأسهم
+47.00
+3.09%
نطاق اليوم
1530.00 - 1569.50
ISIN
N/A
المصدر
Cboe
-
AstraZeneca And Daiichi Sankyo Withdraw EU Marketing Application For Datopotamab Deruxtecan
24 ديسمبر 2024 02:40:25 بحسب NASDAQ US Markets
-
22 ديسمبر 2024 06:16:51 بحسب NASDAQ US Markets
-
3 Unstoppable Stocks to Buy Right Now
15 ديسمبر 2024 06:33:05 بحسب NASDAQ US Markets
-
March 2025 Options Now Available For AstraZeneca (AZN)
06 ديسمبر 2024 11:01:12 بحسب NASDAQ US Markets
-
AZN : TROPION Analysis Reveals Datopotamab Deruxtecan Efficacy In Advanced EGFR-Mutated Lung Cancer
05 ديسمبر 2024 22:31:29 بحسب NASDAQ US Markets
-
FDA Approves AstraZeneca's Imfinzi For Limited-Stage Small Cell Lung Cancer
04 ديسمبر 2024 21:59:20 بحسب NASDAQ US Markets
-
AstraZeneca Names A MSK Leader To Global Cancer Post
25 نوفمبر 2024 11:17:34 بحسب Forbes - World
-
Lunit Collaborates With AstraZeneca To Develop AI-powered Digital Pathology Solutions
18 نوفمبر 2024 13:17:39 بحسب NASDAQ US Markets
-
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
14 نوفمبر 2024 07:43:11 بحسب NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript
12 نوفمبر 2024 17:04:51 بحسب NASDAQ US Markets
-
AstraZeneca To Invest $3.5 Bln In US To Expand R&D And Manufacturing
12 نوفمبر 2024 03:02:49 بحسب NASDAQ US Markets
-
AstraZeneca Q3 Net Income Rises; Upgrades 2024 Guidance
12 نوفمبر 2024 03:02:49 بحسب NASDAQ US Markets
-
AstraZeneca : Wainzua Recommended By CHMP For EU Approval In Hereditary Transthyretin Amyloidosis
21 أكتوبر 2024 03:00:49 بحسب NASDAQ US Markets
-
AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
08 أكتوبر 2024 14:20:34 بحسب NASDAQ Stocks
-
Arcus Announces Clinical Trial Collaboration With AstraZeneca To Evaluate Casdatifan
02 أكتوبر 2024 17:15:33 بحسب NASDAQ US Markets
-
AstraZeneca Becomes Oversold (AZN)
24 سبتمبر 2024 18:47:41 بحسب NASDAQ US Markets
-
AstraZeneca Becomes Oversold (AZN)
24 سبتمبر 2024 18:45:01 بحسب NASDAQ Stocks
-
CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease
24 سبتمبر 2024 13:14:18 بحسب NASDAQ Stocks
-
AstraZeneca: TROPION-Breast01 Phase III Trial Fails To Achieve Statistical Significance
23 سبتمبر 2024 03:29:23 بحسب NASDAQ US Markets
-
AZN : IMFINZI Regimen Reduces Death Risk By 25% In Late-Stage Muscle-Invasive Bladder Cancer Trial
15 سبتمبر 2024 13:57:59 بحسب NASDAQ US Markets